Lithium activates brain phospholipase A2 and improves memory in rats: implications for Alzheimer’s disease
- 11 December 2015
- journal article
- research article
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 266 (7) , 607-618
Abstract
Phospholipase A2 (Pla2) is required for memory retrieval, and its inhibition in the hippocampus has been reported to impair memory acquisition in rats. Moreover, cognitive decline and memory deficits showed to be reduced in animal models after lithium treatment, prompting us to evaluate possible links between Pla2, lithium and memory. Here, we evaluated the possible modulation of Pla2 activity by a long-term treatment of rats with low doses of lithium and its impact in memory. Wistar rats were trained for the inhibitory avoidance task, treated with lithium for 100 days and tested for perdurability of long-term memory. Hippocampal samples were used for quantifying the expression of 19 brain-expressed Pla2 genes and for evaluating the enzymatic activity of Pla2 using group-specific radio-enzymatic assays. Our data pointed to a significant perdurability of long-term memory, which correlated with increased transcriptional and enzymatic activities of certain members of the Pla2 family (iPla2 and sPla2) after the chronic lithium treatment. Our data suggest new possible targets of lithium, add more information on its pharmacological activity and reinforce the possible use of low doses of lithium for the treatment of neurodegenerative conditions such as the Alzheimer’s disease.Keywords
Funding Information
- FAPESP (04/02165-8, 02/13633-7, 09/52825-8)
- ABADHS
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 91 references indexed in Scilit:
- Does Lithium Prevent Alzheimerʼs Disease?Drugs & Aging, 2012
- Differentiating the Cognitive Profile of Schizophrenia from That of Alzheimer Disease and Depression in Late LifePLOS ONE, 2010
- The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR ExperimentsClinical Chemistry, 2009
- Intoxications aiguës au lithium : revue de la littérature et étude de cas cliniquesTherapies, 2009
- The GSK3 hypothesis of Alzheimer’s diseaseJournal of Neurochemistry, 2007
- Lithium Therapy Improves Neurological Function and Hippocampal Dendritic Arborization in a Spinocerebellar Ataxia Type 1 Mouse ModelPLOS Medicine, 2007
- Neuroprotective and Neurotrophic Actions of the Mood Stabilizer Lithium: Can It Be Used to Treat Neurodegenerative Diseases?Critical Reviews™ in Neurobiology, 2004
- Treatment Research in Bipolar DisorderCNS Drugs, 2002
- Arachidonic Acid as a Messenger for the Expression of Long-Term PotentiationBiochemical and Biophysical Research Communications, 1999
- Relevanz des Metabolismus der Membranphospholipide für die Alzheimer-DemenzFortschritte der Neurologie · Psychiatrie, 1996